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The objective of this study was to establish the repeatability and reproducibility limits 
of several volume related PET image derived indices, namely tumour volume (TV), 
SUVmean, and Total Glycolytic or Proliferative Volume (TGV, TPV), relative to that of 
SUVmax, commonly employed in clinical practice 
Methods: Fixed and adaptive thresholding, fuzzy C-means (FCM) and fuzzy locally 
adaptive bayesian (FLAB) were considered for TV delineation. Double baseline 18-
FDG (17 lesions, 14 esophageal cancer patients) and 18-FLT (12 lesions, 9 breast 
cancer patients) PET scans acquired at a mean of 4 days interval and prior to any 
treatment were used for reproducibility evaluation. The repeatability of each method 
was evaluated on the same datasets and compared to manual delineation.  
Results: A negligible variability of <5% was measured for all segmentation 
approaches in comparison to manual delineation (5%-35%). SUVmax reproducibility 
levels were similar to others previously reported with a mean percentage difference 
of 1.8%±16.7% and -0.9%±14.9% for the FDG and FLT lesions respectively. The 
best TV and TGV/TPV reproducibility limits ranged from -21% to 31% and -30% to 
37% for FDG and FLT images respectively, whereas the worst reproducibility limits 
ranged from -90% to 73% and -68% to 52% respectively.  
Conclusion: The reproducibility of estimating TV, SUVmean and derived TGV/TPV was 
found to vary among segmentation algorithms. Some differences between FDG and 
FLT scans were observed mainly due to differences in overall image quality. The 
smaller reproducibility limits for volume derived image indices were similar to those 
for SUVmax, suggesting that the use of appropriate delineation tools should allow 




Most of current PET clinical practice for diagnosis, staging, prognosis, therapy 
response assessment and patient follow-up rely on manual and visual analysis (1). 
The index most commonly employed in PET clinical studies is the standardized 
uptake value (SUV). In order to obtain this index of activity accumulation a region of 
interest (ROI) should be determined, usually drawn manually or using some fixed 
threshold. Despite not being the only factor that can affect the accuracy of SUVs, the 
type and size of ROI is a large contributor to the variability of such measures as has 
been previously demonstrated (2,3). A popular alternative is the use of the pixel with 
the maximum activity value, usually referred to as SUVmax. A large number of studies 
have demonstrated its prognostic and predictive value, despite the fact that it is 
sensitive to image noise (4,5). On the other hand, there are a limited number of 
mostly recent studies that have explored the use of overall tumor volume (TV) as an 
index for prognosis and response assessment (6-8) considering either the TV alone 
or in combination with the mean SUV (SUVmean) to form the total glycolytic or 
proliferative (for FDG and FLT respectively) volume (TGV/TPV), defined as the 
product of TV x SUVmean (9-11).  
Clearly one of the issues associated with the use of functional volumes 
derived from PET images, which is directly responsible for the reduced use of such 
indices, is the accuracy, robustness, repeatability and reproducibility considering the 
delineation. On the one hand, manual delineation of functional volumes using PET 
images leads to high inter- and intra-observer variability (3), principally arising from 
the poor quality of PET images. On the other hand, current state-of-the-art algorithms 
for functional volume segmentation consist of fixed (12) or adaptive thresholding 
approaches (13,14). Although attractive as a result of the easiness of use, the 
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drawbacks of fixed threshold approaches are numerous, since the value of the 
threshold to be used for each lesion clearly depends on multiple factors, such as 
lesion contrast and size as well as image noise (15). The solutions based on the use 
of adaptive thresholding consider the contrast between the object to delineate and its 
surrounding background. However, they require imaging system specific optimisation 
carried out considering uniformly filled spherical lesions reducing the robustness of 
the approach, particularly in the case of multi-centre trials. In addition, their 
performance depends on the background ROI choice which can in turn lead to 
reduced inter-observer reproducibility for functional volume determination. A few 
automatic algorithms have been recently proposed (16-19). The main difference 
between these algorithms and the threshold-based approaches is that they 
automatically estimate the parameters of interest and find the optimal regions’ 
characteristics in a given image without system-dependent parameters. This may 
allow reducing issues associated with deterministic approaches based on 
thresholding, potentially increasing the robustness and reproducibility of PET 
functional volumes determination (20).   
Establishing the level of reproducibility and repeatability is essential in the use 
of any image derived index and its use in prognostic or therapy response studies, 
allowing the evaluation of which change between two studies can be considered 
significant. To date there have only been a limited number of reproducibility studies 
(21-25), almost exclusively concentrating on SUVmax and SUVmean variability in 
double baseline FDG PET scans, showing a relative absolute percentage difference 
of up to 13% with a standard deviation of 10%. The reproducibility of quantitative 
indices (Patlak influx constant, Ki), associated with the acquisition of dynamic 
datasets, have been also assessed (21,22) showing similar levels of reproducibility 
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(mean percentage difference of 8%-10%). Studies on the reproducibility of such 
indices in the case of FLT PET imaging has shown that changes larger than 15-20% 
and 25-30% may be considered significant in SUVmean (obtained using a 41% fixed 
threshold) and SUVmax or Ki respectively (26,27).  
In the majority of these studies, SUVmean values have been calculated using 
manually drawn ROIs or a single fixed threshold (varying from 40% to 75% of the 
maximum activity). Among these studies only one has considered the reproducibility 
of metabolic functional volumes, using fixed threshold. Krak et al (3) have shown a 
mean percentage difference in the ROI volumes of 23±20% and 55±35% for a fixed 
threshold of 50% and 75% respectively. Finally, according to our knowledge there 
has been no published study evaluating the reproducibility of the TGV/TPV.      
To date, despite numerous studies assessing the accuracy of different 
segmentation algorithms there is a lack of evaluation of the repeatability and 
reproducibility of these algorithms relative to different threshold and automatic based 
delineation approaches. Therefore the main objective of this study was to assess the 
repeatability and reproducibility in determining 3D functional volumes and associated 
indices (SUVmean, TGV/TPV) in PET imaging using different algorithms. The 
reproducibility on SUVmax was also included since it represents the index mostly used 
today in clinical practice as well as in order to facilitate a direct comparison with 
previous studies. This evaluation was carried out on double baseline FDG and FLT 
clinical PET datasets. 
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2. Materials and methods 
2.1 Segmentation algorithms considered 
 Four approaches were used in this work. Two different fixed thresholds (12) 
were considered, at 42% (T42) and 50% (T50) of the maximum voxel value, using a 
region growing algorithm with the maximum intensity voxel as seed.  
 An adaptive thresholding (TSBR) (13) was also included:  





       (1) 
SBR is the source-to-background ratio, defined as the contrast between a manually 
defined background region of interest (ROI) and the mean of the maximum intensity 
voxel and its eight surrounding neighbours in the same slice. The parameters (a,b) 
are optimised through linear regression analysis for a given scanner using phantom 
acquisitions of various sphere sizes and contrast. 
 For automatic segmentation approaches, the Fuzzy C-Means (FCM) (28) 
clustering algorithm was considered with two clusters (background and lesion). This 
algorithm has been previously used for functional volume segmentation tasks in both 
brain and oncology applications (29,30) and iteratively minimizes a cost function of 
the voxels intensity values in order to estimate the centre of each cluster and 
membership of each voxel to these clusters. The second automatic algorithm 
considered was the fuzzy locally adaptive Bayesian (FLAB) (19) methodology, based 
on a combination of statistical models with a fuzzy measure in order to 
simultaneously address both issues of noise and blur resulting from partial volume 
effects (PVE) in PET images. FLAB is also able to deal with strongly heterogeneous 
uptake in complex-shaped tumours and generate non binary segmented volumes by 
considering three classes and the associated fuzzy transitions (31). Estimation of the 
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parameters required for the segmentation (Gaussian mean and variance of each 
class and spatial priors for each voxels) are estimated using the iterative Stochastic 
Expectation Maximization (SEM) procedure. For all approaches, the tumours were 
delineated after having been isolated in a 3D box of interest previously defined and 
fixed for all segmentation methodologies (manual and automatic). 
 
2.2 Repeatability, reproducibility: definitions 
 Within the context of this study repeatability is defined as the ability of a given 
segmentation algorithm to reach the same result regarding the definition of a 
functional volume when applied multiple times on a single image. In such a task 
entirely deterministic fixed threshold approaches (T42,T50) will always give the same 
result. On the other hand, more advanced methods, like adaptive thresholding or 
automatic algorithms, such as FCM and FLAB considered here, are susceptible to 
give different results when applied multiple times on the same image. The adaptive 
thresholding segmentation, for instance, depends on a manually drawn background 
ROI and may thus result in variable delineation depending on the choice of this ROI. 
On the other hand, FCM and FLAB are iterative procedures that may not converge to 
the same result at each execution. Finally, manual delineation may be considered as 
the least repeatable, even when considering a single operator (intra-operator 
variability). A second aspect considered in this study was in terms of the impact of a 
segmentation algorithm on the reproducibility of determining functional volumes from 
two baseline PET scans.  
 Two different clinical datasets were used comprising of esophageal and breast 
cancer patients scanned with 18F-FDG and 18F-FLT respectively. In both cases, two 
consecutive PET scans were acquired at few days interval (see section 2.3). We 
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therefore studied the differences in derived functional tumour volumes, lesion 
SUVmean, and total glycolytic/proliferative volumes extracted from both images. 
Repeatability of measuring tumour volumes using the various delineation approaches 
considered in this study was investigated on the same clinical datasets. 
 
2.3 Validation studies 
 Fourteen whole body 18F-FDG PET/CT images acquired on patients with 
esophageal cancer (total of 17 lesions), and nine 18F-FLT PET/CT acquisitions of 
breast cancer patients (12 lesions total) were considered. Esophageal cancer 
patients’ images were acquired at 3.4±2.2 days interval on a Philips GEMINI PET/CT 
scanner with 2min acquisition per bed position, 60min after 18F-FDG injection of 
6MBq/kg. Data was reconstructed using RAMLA 3D with standard clinical protocol 
parameters (2 iterations, relaxation parameter of 0.05, 5mm FWHM 3D Gaussian 
post-filtering). 18F-FLT-PET images were acquired on patients with breast cancer 
(27), for which two scans were performed within 2-7 days (median 4.1) of each other 
prior to treatment. All patients received a single bolus intravenous injection of 18F-
FLT (153-381 MBq) over 30s, and dynamic PET scanning was performed for 95 min. 
Patients were scanned on a CTI/Siemens ECAT962/HR+ PET scanner and data was 
reconstructed using OSEM (360 iterations, 6 subsets, no post-filtering). 
 In both cases two baseline scans were acquired within an average of 3-4 days 
from each other. As no treatment was administered between the two baseline scans, 
and considering the short time between the two acquisitions the assumption is that 
no significant physiological changes occurred in between. A similar assumption has 
been previously used in all other studies evaluating the reproducibility and 
repeatability of different SUV measures in PET imaging with double baseline scans 
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carried out within 5-10 days from each other (21-25). Figure 1 shows the two 
baseline scans for one (a) esophageal and (b) breast cancer patient. 
 
2.4 Analysis  
 For the repeatability evaluation, the tumours in the first image for each patient 
were segmented ten times each with FCM, FLAB, and TSBR. In addition, manual 
delineation was carried out by two nuclear medicine experts. More specifically the 
two experts performed ten different slice-by-slice manual delineations for the different 
lesions considered in a randomised fashion, ensuring a minimum of a week between 
two consecutive delineations of the same lesion. All these manual segmentations 
were carried out under the same conditions of full range contrast display. The mean 
percentage variability and associated standard deviation with respect to the mean 
segmented volume was computed for each of the lesions and segmentation 
approaches across the ten executions and across the ten manual delineations, in 
order to assess the repeatability of the approaches. The repeatability of the manual 
delineations from the two experts were compared separately (intra-observer 
variability) and to each other (inter-observer variability) using intra-class coefficients 
(ICCs). 
 To study the relative impact of the different segmentation algorithms on the 
reproducibility of deriving different PET image indices, tumour volumes were 
segmented independently on both baseline scan images for each lesion, using all the 
different automatic segmentation approaches considered (see section 2.1). 
Subsequently, TV (in cm3), SUVmean, TGV and SUVmax quantitative values M were 
computed for each delineated lesion and compared between the two scans using the 












    (2) 
The distribution of the differences between each pair of measurements was 
assessed for each of the considered index using the Kolmogorov-Smirnov test, 
showing no significant differences from a normal distribution (see figure 2). Bland-
Altman analysis (32) was subsequently used to highlight differences between 
segmentation methodologies. Mean and standard deviation (SD) of differences as 
well as the respective 95% confidence intervals (CI) were obtained. In order to define 
the reproducibility limits (normal range of spontaneous changes) the 95% CI for the 
difference between two measurements were computed as the mean difference ±1.96 
times the SD of the difference. In order to investigate any potential correlations in the 
measured reproducibility the magnitude of the percentage difference for the TV, 
SUVmax and SUVmean measurements were compared to the average of the tumour 
volumes using Pearson correlation coefficient r. This analysis was repeated to 
investigate the correlation of the reproducibility of the different parameters with the 
SUVmean.   
 
3. Results 
Table I contains the mean variability and standard deviation around the mean 
segmented volume across the ten manual delineations performed from each of the 
two nuclear medicine experts, and 10 repeated executions of the FLAB, FCM and 
TSBR algorithms. Results on both clinical datasets are presented separately. FLAB 
demonstrated highly repeatable results in all of the studied cases, with negligible 
variability (1%) around the mean segmented 3D volumes across the different 
repeated executions. FCM also lead to satisfactory repeatability results (1.4±1.6% for 
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the FDG cases and 2.3±1.9% for the FLT cases). In comparison, the use of the 
TSBR led to more than twice as high variability (2.9±2.7% and 4.7±3.6% for the FDG 
and FLT cases respectively). By contrast manual segmentation by the two experts 
showed high intra-observer variability for FDG esophageal lesions (14.1±12.1% and 
16.4±11.3% for expert 1 and 2 respectively). Inter-observer variability was 
17.1±14.3% with an ICC of 0.67 (CI: 0.39-0.89). In the case of FLT, this variability 
was even higher, with intra-observer variability of 22.1±18.7% and 23.8±17.8% for 
expert 1 and 2 respectively and an inter-observer variability of 27.4±21.9% with ICC 
0.59 (CI: 0.31-0.84). 
 Tables II and III contain a summary of the reproducibility results for the 
different parameters computed from Bland-Altman plots on the two consecutive 
baseline scans for FDG esophageal and FLT breast lesions respectively. The 
observed reproducibility of SUVmax and SUVmean measurements for the volumes 
obtained using TSBR and FLAB is illustrated in figure 3. The corresponding plots for 
TV are shown in figures 4(A) and 4(B) using TSBR and FLAB respectively.  
 Concerning the reproducibility of SUVmax similar percentage differences were 
measured for the FDG and FLT datasets with a SD of the mean percentage 
difference of 16.7% and 14.9% respectively. The upper and lower percentage 
reproducibility limits for the SUVmax was -31% to 35% and -30% to 28% for the FDG 
and FLT datasets respectively. On the other hand the automatic approaches led to 
FDG TV measurement reproducibility limits of -21% to 31% and -51% to 52% for the 
FLAB and the FCM algorithms respectively. A poorer reproducibility of the FDG TV 
measurements was observed for the threshold based approaches with upper and 
lower reproducibility limits of -90% to 51% and -69% to 73% for the adaptive and T42 
respectively. In the case of FLT TV measurements, the reproducibility was similar to 
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FDG for the threshold based approaches, while a deterioration in the reproducibility 
obtained with the automatic approaches was observed particularly for the FCM 
algorithm with reproducibility limits of -66% to 74%.      
 SUVmean measurements using FLAB exhibited reproducibility levels of similar 
magnitude to that for the TV definition, with a SD of the mean percentage difference 
of 15.6% and 14.1% for the FDG and FLT datasets respectively. This was however 
not the case for the other tumour delineation algorithms considered, with the larger 
SUVmean reproducibility limits using the FCM tumour definition (-77% to 62% and -
59% to 59% for the FDG and FLT datasets respectively). Finally, the smaller SUVmean 
reproducibility for the threshold based approaches was obtained using T50, for both 
the FDG and FLT datasets with a mean percentage difference of -10.5±23% and -
13.3±16.8% respectively. 
 The reproducibility of TGV/TPV, being the product of TV and SUVmean, was 
dependent on the direction of changes for both TV and SUVmean. As an increase 
(respectively decrease) of TV was correlated with a decrease (respectively increase) 
of SUVmean (p<0.002, r=0.54, 0.67, 0.72 for FLAB, TSBR and T42 respectively), 
TGV/TPV reproducibility levels were generally similar in magnitude to the TV and 
SUVmean considered separately. However, in certain cases there were more 
increases or decreases of both TV and SUVmean for a given patient, resulting in larger 
variability of the TGV/TPV measurements (for example the TSBR measurements of 
the FLT breast lesions, with 22.1±48.9% for the TPV whereas TV and SUVmean were 
11.3±31.4% and -3.2±26.5% respectively). 
 The TV reproducibility results were dependent on the measured TV with a 
larger variability seen for smaller tumours. This dependence was statistically 
significant for the adaptive thresholding (r=0.37, p=0.046, see figure 5(A)) with 
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differences higher than 30% on average (up to 75%) in several of the tumours below 
50cm3. On the other hand this dependence was not significant for FLAB (r=0.27, 
p=0.16, figure 5(B)) with most differences <30% irrespective of TV, further 
demonstrating improved robustness as previously shown (19,20). In terms of the 
SUVmax reproducibility results there was no statistically significant trend with either 
the lesion size (r=0.016, p=0.93, figure 5(C)) or the mean of the two measured 
SUVmean values (r=0.14, p=0.49). Finally no statistically significant trends were found 
for the SUVmean reproducibility depending on the lesion size irrespective of the 




 Functional volume delineation represents today an area of interest for multiple 
clinical (routine and research) applications of PET imaging (prognosis, response 
prediction, therapy assessment, radiotherapy treatment planning). In all of these 
applications, the repeatability and reproducibility with which functional volumes can 
be determined under different imaging conditions plays a predominant role, allowing 
a level of confidence to be established in the use of such tumour volume 
measurements. Volume definition methodologies currently used in clinical practice 
are based on the use of manual delineation or fixed and adaptive thresholding (12-
14), while several promising automatic algorithms have been recently proposed (16-
19). The major drawback of manual delineation is high inter- and intra-observer 
variability in addition to being time consuming. On the other hand, currently 
considered state of the art adaptive threshold based algorithms have been shown to 
accurately define functional volumes under certain imaging conditions of spherical 
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and homogeneous activity distribution lesions. However, adaptive thresholding 
approaches usually involve some user interaction to select background regions of 
interest, which can potentially lead to user introduced variability. Although signal 
intensity reproducibility, predominantly considering the use of SUVmax, has been 
previously assessed, the potential of new indices such as tumour volume and/or 
TGV/TPV can be only considered following the assessment of their reproducibility 
which has not been previously widely assessed. Therefore in this study the 
reproducibility limits of these indices, in comparison to other indices considered as 
the current gold standard, have been assessed using different tumour delineation 
methodologies on double baseline FDG and FLT datasets.  
In terms of repeatability, all algorithms considered exhibited mean differences 
<5%, with automatic approaches coming closer to the perfect repeatability that can 
be achieved by deterministic approaches such as a fixed threshold. The repeatability 
of both threshold and automatic segmentation approaches was superior to that of 
manual delineation. This of course should be considered within the context of the 
limited absolute accuracy of thresholding, particularly for non-homogeneous in form 
and activity distribution lesions (31).  
The variability in the SUVmax observed in this work is similar to that measured 
in previous reproducibility studies, with similar percentage differences for FDG and 
FLT datasets, suggesting that differences larger than -30% can be considered as 
significant in treatment response, while changes above 35% (30% for FLT) may be 
indicative of no response. Depending on the delineation algorithm used, the mean 
percentage difference and corresponding SD for TV measured on the two baseline 
scans varied from 5%±13% (4%±16%) to -19%±36% (10%±35%) for the FDG (FLT) 
datasets. The smallest TV reproducibility limits obtained were similar to those for 
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SUVmax, ranging from -21% to 31% and -27% to 35% for FDG and FLT respectively, 
suggesting in turn that, depending on the segmentation algorithm used, similar to 
SUVmax confidence intervals may be considered for monitoring therapy response 
based on functional TV. Similarly in the case of TGV/TPV the smallest reproducibility 
limits measured were between -16% to 26% and -30% to 37% for FDG and FLT 
respectively. On the other hand, the largest reproducibility limits for the FDG TV and 
TGV ranged from -90% to 73% and -68% to 52% respectively.  
 Reproducibility ranges obtained on the FDG esophageal lesions were almost 
systematically smaller than the ones obtained on the FLT breast lesions dataset, 
which can be attributed to the higher level of noise and overall lower contrast 
observed in the FLT cases, resulting in less robust delineations. In addition, FDG 
esophageal lesions tended to appear more homogeneous than breast lesions. For 
instance, FCM which incorporates neither noise nor spatial modelling is associated 
with a larger mean TV variability on the FLT dataset relative to FDG, whereas FLAB 
exhibits similar reproducibility levels for both. This highlights the need for a robust 
delineation tool ensuring high reproducibility in an environment of substantial image 
quality variability, likely for example to be encountered in multi-center trials where the 
use of functional TV as a measure of response to therapy may be considered. 
 T50 uses a more restrictive threshold than 42% and is therefore less prone to 
large over-evaluation of low contrast (<4:1) and/or small size (<2cm in diameter) 
tumor volumes. It led to systematically lower variability than T42. Finally, the adaptive 
thresholding methodology did not demonstrate better reproducibility than fixed 
thresholding, which can be attributed to the use of the background ROI placed 
manually on both scans, combined with the fact that background activity may also 
vary between the two scans. 
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 Although a potential criticism for the current study can be the lack of ground-
truth for the functional volumes, the aim of this work was not to assess the absolute 
accuracy of algorithms, which has been previously assessed for the approaches 
used in this work (19,31). The objective was to assess the reproducibility limits of 
functional volume related indices that can be attained depending on the algorithm. 
Within this context, the repeated studies of the double baseline acquisitions have 
been performed within an average of 3-4 days from each other without any treatment 
between them, matching that used by all other reproducibility studies to date (21-25). 
Finally the reproducibility of the SUVmax was included in this work as the current gold 
standard facilitating at the same time the comparison of our reproducibility study to 
those performed previously. The SUVmax reproducibility limits obtained in this work for 
both FDG and FLT agree closely with those of previous studies.  
 
5. Conclusion 
 The smaller reproducibility ranges obtained for the different image indices 
considered in this study, similar to those of SUVmax, suggest that new automatic 
segmentation approaches may facilitate the introduction of tumour volumes or a 
combination of tumour volumes and signal intensity in the form of total 
glycolytic/proliferative volumes derived from PET images for therapy response 
studies. However, our results also demonstrate that the reproducibility of different 
quantitative parameters associated with functional volumes depends significantly on 
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5 ± 13.3 
 
-1.8 to 11.9 -21.1 -33 to -9.1 31.1 19.2 to 43 
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Table I: Repeatability evaluation: mean variability and standard deviation around the 
mean segmented volume for repeated delineations of 17 esophageal and 12 breast 
lesions on the first baseline FDG and FLT scans respectively.  
 
Table II: Reproducibility results concerning the FDG esophageal lesions with 
differences of scan #2 measurements with respect to scan #1. 
 
Table III: Reproducibility results concerning the FLT breast lesions with differences of 
























































































































































































































































































































Figure 1: Example of two baseline images (A). FDG (esophagus) and (B). FLT 
(breast). 
 
Figure 2: Normal plots showing that the distributions of differences for (A). SUVmean 
(FLAB), and (B). TV (FLAB) between two scans are not significantly different from 
normality. 
 
Figure 3: Bland-Altman plots of (A). SUVmax, (B). SUVmean (adaptive thresholding), 
and (C). SUVmean (FLAB) values for both FDG and FLT lesions. The lines show the 
combined mean, 95% CI as well as upper and lower reproducibility limits. Individual 
values for the FDG and FLT lesions are shown in tables II and III respectively. 
 
Figure 4: Bland-Altman plots of (A). TV (adaptive thresholding), and (B). TV (FLAB) 
for both FDG and FLT lesions. The lines show the combined mean, 95% CI as well 
as upper and lower reproducibility limits. Individual values for the FDG and FLT 
lesions are shown in tables II and III respectively. 
 
Figure 5: Differences between (A-B). tumor volumes and (C). SUVmax measured in 
two baseline scans in relation to the average tumour volume obtained using adaptive 
thresholding (A), and FLAB (B-C). 
